News Room

Adcock Ingram Enters Into Discussions With CFR Pharmaceuticals To Create A Leading Global Emerging Markets Pharmaceuticals Company

2013/07/03 00:00:00
The Independent Board of Adcock Ingram today announced that it has entered into discussions with CFR Pharmaceuticals S.A. (CFR) – a multinational emerging markets pharmaceutical company based in Chile – that may lead to CFR making a cash and share offer to acquire 100% of Adcock’s entire share capital. The transaction, if implemented, would create a merged company with combined revenues of approximately US$1.3 billion (approximately ZAR12.1 billion).
[READ MORE]

19 Western Cape children given the gift of a smile

2013/06/17 00:00:00
Children from disadvantaged backgrounds to receive facial reconstructive surgery free of charge during Adcock Ingram Smile Week
[READ MORE]

New Executive Appointments at Adcock Ingram

2013/06/13 00:00:00
Adcock Ingram has recently restructured its management profile with two new additions to the leadership team. Werner van Rensberg has been appointed as the new Chief Operations Officer, and Doreen Kosi as the new Government Relations Executive.
[READ MORE]

Adcock Ingram Reports Improved Trading Performance Despite Difficult Market Conditions

2013/06/04 00:00:00
Adcock Ingram today announced its results for the six month period ended 31 March 2013.
[READ MORE]

Adcock Ingram Receives FDA Accreditation For Its Wadeville Manufacturing Facility

2013/03/28 00:00:00
Adcock Ingram today announced that the Centre for Drug Evaluation and Research of the US Food and Drug Administration (FDA) has accredited the company’s Wadeville Manufacturing facility, located in Germiston, East of Johannesburg. Adcock’s Wadeville pharmaceutical facility is also certified by the Medicines Control Council (MCC) of South Africa as a current Good Manufacturing Practice facility.
[READ MORE]

Adcock Ingram Close Indian Acquisition

2013/01/18 00:00:00
Adcock Ingram today announced the completion of the acquisition of Cosme Farma Laboratories Limited, a pan-Indian pharmaceutical company based in Goa, India for R745 million.
[READ MORE]